CN1269245A - Static hydraulic process to prepare influenza virus vaccine - Google Patents
Static hydraulic process to prepare influenza virus vaccine Download PDFInfo
- Publication number
- CN1269245A CN1269245A CN 00110211 CN00110211A CN1269245A CN 1269245 A CN1269245 A CN 1269245A CN 00110211 CN00110211 CN 00110211 CN 00110211 A CN00110211 A CN 00110211A CN 1269245 A CN1269245 A CN 1269245A
- Authority
- CN
- China
- Prior art keywords
- influenza virus
- vaccine
- influenza
- hydrostatic
- technology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A preparation method of influenza virus vaccine by using static water pressure technology and inactivation process includes the following steps: selecting toxic inoculum, making inoculation on 8-11 day-aged chick embryo and incubation at 34 deg.c, after 48-72 hr, collecting allantoic fluid, ultrafiltration and concentration, ultracentrifugation and purification, passing through column chromatography, intermediate production detection, univalent virus suspension combination, static water pressure inactivation, finished product inspection and end product packaging. Said invention combines the modern high-pressure physical technology with biological technology, not only retains complete structure of influenza whole virus, but also completely inactivates said virus, and its immunogenicity of its antigen also is not affected but raised, and so it is suitable for influenza viruses with variation and multi-variety. It is simple in production process, short in production period, and low in cost.
Description
The present invention relates to inactivated influenza virus vaccine in the medicine bioengineering goods, particularly influenza virus hydrostatic pressing technology inactivation technology prepares the method for vaccine.
Influenza is the acute respiratory infectious disease that is caused by influenza virus.Influenza virus is divided into first, second, the third three types, and wherein first type viral infectivity morphs the most by force and easily, and spread speed is the fastest.New subspecies appear in the constant generation antigenic variation of influenza virus, and general 10-15 takes place by once worldwide being very popular; The various places of being everlasting regional popular spring and autumn take place.The injection vaccinum influenzae inactivatum is a kind of method of effective flu-prevention.The preparation influenza vaccines must adopt WHO to recommend strain to make inactivated vaccine in conjunction with various countries' practical situation with first 1, first 3 and B-mode trivalent influenza virus.The selection of inactivator and application process are the key technologies in the inactivated vaccine preparation.Chemical reagent formaldehyde (formalin) is to use the earliest inactivator the most widely, has used till today since U.S.'s approval prepares inactivated influenza virus vaccine with formalin-inactivated from nineteen forty-one always.
Because formaldehyde easily makes virion surface protein antigen impaired, often influences the immunogenicity of vaccine.Formaldehyde has certain zest again simultaneously, and certain side effect is arranged.This vaccine of human vaccination is local and general reaction is all stronger.In order to solve the problem that formalin-inactivated exists, 1960's, the application of supercentrifuge and chromatography chromatographic technique improves the influenza virus purification process greatly, has made the influenza all-virus inactivated vaccine.Yet, when the child uses still untoward reaction can appear.In order to make adverse reaction reduction, and develop multiple decomposition agent, as ether, 3-N-butyl phosphoric acid salt (Tri-N-butylphosphate), polysorbate 80 (Polysorbate80), NaTDC (Sodium deoxy cholate), trinitrotoluene X100 (Triton X100) etc., produced split vaccine, this kind vaccine 1986 goes through to use in the U.S. first.
This century 70 and the eighties, on the basis of split vaccine, developed influenza virus subunit and surface antigen (HA and NA) vaccine again.Britain has confirmed that immune effect is identical with split vaccine, and can be used for the child in clinic trial.Britain in 1980 ratifies to use first, then expands to other country.
Find that in practice though influenza virus subunit and SAV inoculation back untoward reaction reduce to some extent, its immunogenicity all is not so good as the totivirus grain vaccine of purification, from and carried out the adjuvant research work.Utilize adjuvant to improve immune effect.Influenza virus particles HA, NA antigen, cholesterol and detergent (Octyl glucoside-octyl group glycosides) with B30-MDP[6-0-(2-14 alkyl 16 alkane acyls " 2-tetradcylhexdecanoyl ")-N-acetyl muramyl " N-acetylmuramoyl "-L-alanyl " L-alanyl "-D-isoglutamine " D-isoglutamine " and purification mix mutually, make it abundant mixing by ultrasound wave, dissolving is removed detergent through cellulose then.So just can make influenza virion HA and NA subunit inside and outer surface adhere to into the flaky texture of liposome mutually, its diameter is about 100nm, is similar to a complete influenza virus particles.This vaccine, Japan has begun the volunteer on probation, and antibody male rotary is desirable, but still has side reaction, as the injection site pain and redness etc. is arranged.
The objective of the invention is at the deficiencies in the prior art, use modern high-pressure physics and biology and cross one another and permeate a kind of Perfected process of setting up, both influenza virus hydrostatic pressing inactivated vaccine method.It not only keeps the influenza all-virus complete structure and is not destroyed, and virus again can complete inactivation, the unaffected again and star's raising in addition of immunogenicity of antigens simultaneously, fast to the influenza virus variation, how very suitable mutation is, and technology is easy, with short production cycle, totle drilling cost is low, can satisfy the modern industrialization large-scale production.
Influenza virus hydrostatic pressing technology inactivation technology prepares the operational approach of vaccine, get the work seed culture of viruses, inoculate 8-11 day instar chicken embryo and, gather in the crops allantoic fluid after 48-72 hour, ultrafiltration and concentration, ultracentrifugation purification in 34 ℃ of hatchings, cross column chromatography, the semi-finished product calibrating, the unit price viral suspension merges, the hydrostatic pressing deactivation, the finished product calibrating, finished product packing and packing.
One, hydrostatic pressing, high pressure equipment and operation principle thereof
1, hydrostatic pressing
Hydrostatic pressing is the abbreviation of hydrostatic pressure.Solid, liquids and gases all are considered as continuous media.Under external force, the each several part medium is executed equal and opposite in direction, direction opposite effect power mutually by the separating surface between them, and being called the power that is used on the unit interfacial surface is stress.Can resolve into two components to stress: one is called direct stress perpendicular to acting surface, and σ commonly used represents; Another claims shearing stress in acting surface, T commonly used represents.Can prove that the stress state of any point can represent that stress tensor has 9 components, is expressed as with symmetric stress tensor in the medium:
Wherein, σ x, σ y, σ z are respectively that the remainder of medium is to the direct stress of the volume element in the medium in x, y, z direction; Tij (I, j=x, y, z) is 6 shearing stress, the direction of previous foot mark generation one shearing stress, and a back foot mark is represented the exterior normal direction of shearing stress acting surface.
Definition pressure is p=-(σ x+ σ y+ σ z)/3, promptly the size of pressure equal the meansigma methods of 3 direct stress on investigating a little, negative sign represents that the action direction of pressure is opposite with the exterior normal direction of the acting surface of crossing this point.Distinguishingly, if fluid remains static, though perhaps be kept in motion, fluid is noncohesive, and its 6 shearing stress components all equal zero, and has only 3 direct stress non-vanishing.Can prove
σ x=σ x=σ z=-P, promptly the pressure of stationary fluid or inviscid fluid equals the negative value that either direction just should be engaged in, and claims that such pressure is hydrostatic pressure.Generalized theory, the characteristics of hydrostatic pressing state are that shearing stress is zero, the direct stress isotropism.In the high-pressure science technical research, general state near the hydrostatic pressing hydrostatic pressing that is as the criterion that claims claims that the state away from hydrostatic pressure is non-hydrostatic pressing.In the experiment measuring of pressure, actual measurement be direct stress on a certain limited area.In the time of in the middle of this area is in fluid, owing to satisfy the hydrostatic pressing condition under the equilibrium state, pressure distribution is uniformly, so can be determined to quite high precision to pressure with the power on the unit are.The acquisition of high accuracy hydrostatic pressing, relevant with the shear strength of selected transmission medium.
So-called transmission medium is meant: the media material that transmits pressure.The basic function of fluid pressure transmission medium is that the axial compressive force of executing thereon is transformed into the uniform pressure that affacts on the sample, promptly is transformed into hydrostatic pressure.Consider reliable, the convenient and safety when using in addition, also require transmission medium to have following rerum natura: chemical inertness, permeability and compression ratio are low, operation easily, sealing is cheap easily.According to different instructions for uses and pressure limit, can select for use different gas, liquid or solid as transmission medium.In general, be transformed into the ability aspect of hydrostatic pressing, gas the best, liquid takes second place, and solid is the poorest, even select for use the very low soft solid of shear strength also can only obtain accurate hydrostatic pressing.Liquid medium commonly used has glycerol, transformer oil, kerosene, gasoline, petroleum ether, penta to wash and the mixed liquor of isopentane and water etc.
Two, brief introduction of hydrostatic pressing machine equipment and operation principle thereof
Normal temperature and pressure hydrostatic press is made up of ultrahigh pressure vessel, hyperpressure source and supporting pipeline fittings system.It makes and is subjected to stampings to obtain each to uniform hyperpressure effect.
The supertension cavity volume is certain, changes cavity internal pressure by oil density in the continuous increase cavity, reaches the purpose of boosting.Pressurization is carried out at normal temperatures.The ascending, descending process of pressing was finished in seconds or tens of seconds, therefore in operating process, whole system can be considered as adiabatci condition, did not have heat exchange with the external world, and promptly Dq=Tds ≈ 0.Because system externally does negative work and positive work respectively in ascending, descending pressure process, thereby internal system has small temperature fluctuation, but do not influence the survival of virus.So the deactivation of virus is by due to pressure fully, rather than temperature causes.
Three, influenza trivalent totivirus mixing suspension hydrostatic pressing deactivation operational approach
1, according to influenza virus vaccine production scale size, introduce or processing and manufacturing is suitable for the hydrostatic press of production scale output, import automaticity height, the general manual operations of own processing and fabricating, medium and small hydrostatic press Japan has approved product to sell; The hydrostatic press Sweden of large-scale production produces; The energy processing and manufacturing of China Shanghai big dragon machinery plant;
2, the selected hydraulic press that is fond of tranquility is placed in the 4-8 ℃ of sterilizing room that meets medicine GMP production procedure requirement, presses energize, and regulation voltage, detection, debugging are to the parameters index that meets production requirement.
3, influenza trivalent totivirus concentrates suspension, behind assay approval, be loaded on good seal in 500ml flexible plastic blood taking bag or the flexible plastic transfusion bag, it is standby to place 4-8 ℃ of refrigerator to preserve, prevent freeze thawing, also can process the soft plastic bag of standard and specialize in the outstanding stream of dress influenza virus, decide 250ml-5000 according to scale and do not wait specification.
4, hydrostatic pressing secret envelope high pressure chest is opened, put influenza trivalent totivirus suspension blood taking bag or plastic bag are housed, selected transmission medium, airtight high pressure chest for use, energized, regulation voltage, selected 200-300Mpa, hydrostatic pressing 20-40 minute;
5, influenza trivalent totivirus suspension is in time deposited in 4-8 ℃ of refrigerator after hydrostatic pressing is handled.
The invention is to utilize contemporary high-pressure physics and the bonded a kind of examination of repaying of biology techniques, has substituted traditional chemical ablation method.The hydrostatic pressing technology is a kind of new method and the means that grew up in recent years.Keep a full stand of seedings simultaneously even improve immunogenicity in order to inactivating influenza virus.Because of the physical method inactivation technology, the residual chemicals composition does not make suitable safety.Make the production of influenza virus vaccine undoubtedly, had great using value and huge economic benefit.
Influenza virus hydrostatic pressing inactivated vaccine is by first 1 (H
1N
1) type: Al/Beijing/262/95, first 3 (H
3N
2) type: A3/SYSNWY/5/97 and B-mode: B/HARBIN/7/94 three influenzae strains virus inoculated into chick embryo respectively, cultivate and gather in the crops allantoic fluid after 48-72 hour, through a series ofly concentrating, column chromatography purification, reaching the multivalent inactivated vaccine of making behind the hydrostatic pressing technological processing craft.
Respectively to fixedly pressurized time, change pressure and fixation pressure, the experiment of change pressurized time of influenza hydrostatic pressing inactivated vaccine.Sample after hydrostatic pressure is handled is carried out TCID50 mensuration respectively, and the result shows: the virus through 250MPa and the processing of above high pressure thereof completely loses infection ability, and is lower than the also obviously decline of its virulence of virus of 250MPa pressure treatment.
Get the virus sample of be inactivated (250MPa), Electron microscope showed has been compared significant change with the normal virus particle on form, and virion convexes to form.Get two parts of same virus sample and extract its total RNA respectively, carry out reverse transcription after, CHBA is carried out agarose gel electrophoresis, analyze the variation of its band spectrum, again in conjunction with the special fragment amplification of HA gene, the two no significant difference as a result, the specific amplified of HA gene is positive.Though the certain hydrostatic pressure of this explanation can make inactivated influenza virus, does not make the fracture of HA genetic fragment.This is because of pressure exerts an influence to the virus surface structural protein, thereby makes its deactivation.
Get influenza hydrostatic pressing inactivated vaccine injection rabbit, blood sampling after fundamental immunity, secondary immunity and three immunity, the centrifuging and taking supernatant obtains experiment and uses serum to be checked, carries out serum neutralization test.The virus of using same treatment simultaneously with formalin-inactivated in contrast.The result shows, is higher than the viral caused NAT 5-10% of usefulness formalin-inactivated far away through the viral caused NAT of hydrostatic pressure deactivation.
Six, further describe the invention below in conjunction with embodiment.
Embodiment 1:
1), the qualified influenza trivalent totivirus suspension 250ml that goes out by the quality standard and the explained hereafter of national regulation;
2) influenza trivalent virion suspension is packed into blood taking bag sealing is with miniature hydrostatic press place
Reason, pressure 250MPa, after the hydrostatic press is handled, puts into 4-8 again at 30 minutes time
In ℃ refrigerator.
Embodiment 2:
1) carries out about 1000 milliliters of trivalent virion suspension by national regulation inactivated influenza virus vaccine production method;
2) selected middle-size and small-size hydrostatic press, the supertension cavity volume once can be handled 1000 milliliters, puts into the hydrostatic press and carries out technical finesse, and plus-pressure all is chosen to be 250MPa, and 30 minutes time, additive method is the same.
Embodiment 3:
1) influenza virus hydrostatic pressing inactivated vaccine large-scale production, the necessary GMP compatible of production environment condition, omnidistance technology of vaccine and quality index must be undertaken by the requirement of influenza vaccines WHO regulation, personnel's technology, equipment, process environments must be supporting;
2) the hydrostatic press needs a big-and-middle-sized flow device, and energy technical office influenza trivalent virion suspension is 5000 milliliters at every turn, is placed in and produces influenza virus vaccine optimised process link, and additive method is the same.
Influenza virus hydrostatic pressing inactivated vaccine system gathers in the crops allantoic fluid by first 1, first 3 and Influenza B virus inoculated into chick embryo, and the viral suspension that the hydrostatic pressing deactivation of concentrated and purified back obtains forms through the phosphate buffer dilution.Guarantee that 0.5ml (everyone divides) contains hemagglutinin first 1, first 3 and B-mode more than 15 μ g.Behind trivalent inactivated influenza virus vaccine immunity white mice, serum reaches 1.6 * 10 respectively to the neutralization index of first 1, first 3 and Influenza B virus behind the serum neutralization test proof vaccine immunity
5, 2.5 * 10
5, 1.6 * 10
5More than, to guarantee immune effect of vaccine.
Influenza virus hydrostatic pressing inactivated vaccine is again through subcutaneous inoculation white mice, and inoculation Cavia porcellus in abdominal cavity was observed 7 days.Whole white mice and Cavia porcellus weight increase, healthy survival does not have any unusual performance.Proof vaccine safety and toxicity test are qualified.And do not have anaphylactogen through irritated originality calibrating proof.
By hydrostatic pressing technical finesse influenza virus grain suspension, through laboratory, pilot scale, different scales productions such as industrialization, confirmation is inactivating influenza virus effectively, can improve immunogenicity again, can also shorten the process time, and is easy again inexpensive, meets modern industrialization production.
Claims (3)
1, a kind of influenza virus hydrostatic pressing technology inactivation technology prepares the method for vaccine, get the work seed culture of viruses, inoculate 8-11 day instar chicken embryo and, gather in the crops allantoic fluid after 48-72 hour, ultrafiltration and concentration, ultracentrifugation purification in 34 ℃ of hatchings, cross column chromatography, the semi-finished product calibrating, the unit price viral suspension merges, the hydrostatic pressing deactivation, the finished product calibrating, finished product packing and packing.
2, influenza virus hydrostatic pressing technology inactivation technology according to claim 1 prepares the method for vaccine, laboratory sample is selected the biological product pharmacy unit of state approval for use, existing quality standard and the living qualified influenza trivalent totivirus suspension 250ml of technology that meets national regulation that produce; With pack into the blood taking bag sealing of influenza trivalent virion suspension, miniature hydrostatic press is handled, pressure 250MPa, after the hydrostatic press is handled, puts into 4-8 ℃ of refrigerator again at 30 minutes time.
3, influenza virus hydrostatic pressing technology inactivation technology according to claim 1 prepares the method for vaccine, carries out about 1000 milliliters of trivalent virion suspension by national regulation inactivated influenza virus vaccine production method; Selected middle-size and small-size hydrostatic press, the supertension cavity volume once can be handled 1000 milliliters, puts into the hydrostatic press and carries out technical finesse, and plus-pressure all is chosen to be 250MPa, 30 minutes time; Additive method is the same.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001102117A CN1147316C (en) | 2000-03-16 | 2000-03-16 | Static hydraulic process to prepare influenza virus vaccine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB001102117A CN1147316C (en) | 2000-03-16 | 2000-03-16 | Static hydraulic process to prepare influenza virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1269245A true CN1269245A (en) | 2000-10-11 |
| CN1147316C CN1147316C (en) | 2004-04-28 |
Family
ID=4580221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB001102117A Expired - Fee Related CN1147316C (en) | 2000-03-16 | 2000-03-16 | Static hydraulic process to prepare influenza virus vaccine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1147316C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100398642C (en) * | 2003-06-20 | 2008-07-02 | 迈克必斯生物系统公司 | Improvements in virus production |
| CN102406930A (en) * | 2011-11-25 | 2012-04-11 | 成都康华生物制品有限公司 | Method for preparing seasonal influenza virus split vaccine |
| CN101804202B (en) * | 2003-02-25 | 2014-06-18 | 米迪缪尼有限公司 | Methods of producing influenza vaccine compositions |
-
2000
- 2000-03-16 CN CNB001102117A patent/CN1147316C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101804202B (en) * | 2003-02-25 | 2014-06-18 | 米迪缪尼有限公司 | Methods of producing influenza vaccine compositions |
| CN100398642C (en) * | 2003-06-20 | 2008-07-02 | 迈克必斯生物系统公司 | Improvements in virus production |
| CN102406930A (en) * | 2011-11-25 | 2012-04-11 | 成都康华生物制品有限公司 | Method for preparing seasonal influenza virus split vaccine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1147316C (en) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5824536A (en) | Influenza virus replicated in mammalian cell culture and vaccine production | |
| CN1020407C (en) | Process for preparation of influenze vaccine | |
| CN103026220B (en) | Fluid mixing in a disposable fluid processing system | |
| Clark et al. | A bacterial lipooligosaccharide that naturally mimics the epitope of the HIV-neutralizing antibody 2G12 as a template for vaccine design | |
| CN102323428A (en) | Riemerella anatipestifer antibody indirect ELISA method detection kit and application thereof | |
| Nuñez et al. | Next-generation computationally designed influenza hemagglutinin vaccines protect against H5Nx virus infections | |
| Compans | Hemagglutination-inhibition: rapid assay for neuraminic acid-containing viruses | |
| CN101974099A (en) | Purification method of tubercle bacilipin Arab mannan and tubercle bacillus diagnostic reagent | |
| CN1147316C (en) | Static hydraulic process to prepare influenza virus vaccine | |
| CN104198736B (en) | The purposes of the duck tembusu virus E protein cAg territory albumen of high-efficiency activated expression | |
| CN101074956A (en) | Immune chromatography test paper for inspecting legionella pneumophilia antibody and its production | |
| Hooks et al. | Characterization and distribution of two new foamy viruses isolated from chimpanzees | |
| CN116693675B (en) | Monoclonal antibody composition of anti-influenza A virus nucleocapsid protein and application thereof | |
| CN106591177B (en) | Low-serum efficient culture medium for mycoplasma capricolum goat pneumonia subspecies and preparation method thereof | |
| CN1324660A (en) | Static water pressure deactivation and nanometer techn. treatment process of influenza virus to prepare lytic vaccine | |
| Seal et al. | Evidence for secondary structure within the virion RNA of echovirus 22 | |
| CN102721812A (en) | Indirect ELISA (enzyme-linked immuno-sorbent assay) kit for detecting nephropathogenic avian infectious bronchitis virus and antibody thereof | |
| Bai et al. | Immunogenicity and antigenicity of rabbit hepatitis E virus-like particles produced by recombinant baculoviruses | |
| CN101376677A (en) | Monoclonal antibody IE5 for detecting new castle disease virus variation strain | |
| Shirvan et al. | Preparation of neuraminidase-specific antiserum from the H9N2 subtype of avian influenza virus | |
| Park et al. | Application of heparin affinity chromatography to produce a differential vaccine without eliciting antibodies against the nonstructural proteins of the serotype O foot-and-mouth disease viruses | |
| CN1148225C (en) | Nanometer-level influenza virus splitting process to make subunit vaccine | |
| CN104502581B (en) | A kind of porcine contagious pleuropneumonia antibody detects by antigen and preparation method | |
| CN1936014A (en) | H5 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein | |
| CN105277694B (en) | Human group A streptococci quantum dot immunochromatography detection card, preparation method and applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |